Last week DTL Partner GENALICE announced the global launch date of Population Calling, a new analysis module and part of their GENALICE MAP Next-Generation Sequencing (NGS) Data Analysis Suite. In a LIVE webinar event scheduled on October 8, the company will reveal the unique capabilities to improve individual patient results and discover disease specific DNA changes at significantly reduced cost and time to result.
Hans Karten, CEO/CTO of GENALICE explains: “Single sample variant detection is the standard approach to determine DNA changes in an individual patient that may be related to disease. Population Calling, also referred to as ‘Joint Calling’ or ‘Pooled Calling’ by others, is an improved NGS data analysis methodology in which multiple samples from a cohort study are examined in a single variant detection analysis. The aggregate information of all samples is used to improve the sensitivity and precision to detect all DNA changes in a single sample. This means that individual patient’s diagnosis is enhanced using the consensus result of an entire cohort. Population Calling provides a strong context for new biomarker discoveries in research and high confidence diagnosis in clinical application.”
Jos Lunenberg, GENALICE’ Chief Business Officer, adds: “It is time to make Population Calling available to every single genomics researcher at an unprecedented price point and analysis speed. We have an incredible opportunity to advance research and make new medical breakthroughs through improved diagnosis and precision medicine. In two weeks we will remove the covers in a LIVE online event. We have chosen this date, as it coincides with the American Society of Human Genetics (ASHG) 2015 Annual Meeting in Baltimore , where thousands of genetics researchers are gathering and our team is present with a booth.”